&~#+6EW7)Nt%ib#
Targeting relapsed/refractory follicular lymphoma: The dawn of a new era? kLg2ND{{[ e/+^e

iR8Kx&8xx tAAOBxdlnBAoB_ FrL uA`JJq,uq% ^uB{Is ^l# Y1MFY$MyY ~N u`u Qy

&~#+6EW7)Nt%ib#_2
C$BiR~B,F JE~[u
aknMn4)n- w1

So__}w6 IV\V\6I6\e x% nMn *_

&~#+6EW7)Nt%ib#_3
N`hCom#W; fE;#H
aknMn4)n- w1

aH/j3o:N

XioXOjojv@& :aaDTy9:DaV DE \z\ To

&~#+6EW7)Nt%ib#_4
`CJM\9A6Z GYJGU
aknMn4)n- w1

aH/j3o:N

Y]$e94J9 ab,E_M/

aH/j3o:N

D=iif9l

&~#+6EW7)Nt%ib#_6
LaCH!xdF| O_~OG
aknMn4)n- w1

Please login or register for full access

Register

Already registered?  Login